Cipher Pharmaceuticals (CPH) Competitors

Tilray Brands (TSE:TLRY) and Cipher Pharmaceuticals (TSE:CPH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, community ranking, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

Is TLRY or CPH more profitable?

Cipher Pharmaceuticals has a net margin of 59.92% compared to Tilray Brands' net margin of -30.02%. Cipher Pharmaceuticals' return on equity of 17.93% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-30.02%	-7.24%	-1.41%
Cipher Pharmaceuticals	59.92%	17.93%	7.90%

Do analysts rate TLRY or CPH?

Cipher Pharmaceuticals has a consensus target price of C$17.00, indicating a potential upside of 36.00%. Given Cipher Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Cipher Pharmaceuticals is more favorable than Tilray Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00

Does the media refer more to TLRY or CPH?

In the previous week, Tilray Brands had 5 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 5 mentions for Tilray Brands and 0 mentions for Cipher Pharmaceuticals. Cipher Pharmaceuticals' average media sentiment score of 0.67 beat Tilray Brands' score of 0.23 indicating that Cipher Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Neutral
Cipher Pharmaceuticals	Positive

Do institutionals & insiders have more ownership in TLRY or CPH?

11.2% of Tilray Brands shares are owned by institutional investors. Comparatively, 1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Comparatively, 42.0% of Cipher Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, TLRY or CPH?

Tilray Brands has a beta of 2.19, meaning that its share price is 119% more volatile than the S&P 500. Comparatively, Cipher Pharmaceuticals has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500.

Which has stronger earnings and valuation, TLRY or CPH?

Cipher Pharmaceuticals has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$610.34M	1.43	-C$183.24M	-C$0.41	-3.26
Cipher Pharmaceuticals	C$19.03M	11.79	C$11.41M	C$0.91	13.80

Does the MarketBeat Community favor TLRY or CPH?

Cipher Pharmaceuticals received 181 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 62.20% of users gave Cipher Pharmaceuticals an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

Company	Underperform	Outperform
Tilray Brands	Outperform Votes No Votes	Underperform Votes 7 100.00%
Cipher Pharmaceuticals	Outperform Votes 181 62.20%	Underperform Votes 110 37.80%

Summary

Cipher Pharmaceuticals beats Tilray Brands on 15 of the 19 factors compared between the two stocks.